Termination of Direct License to Progenics. In the event that the sublicense granted by ProNev to Progenics under the UR Labs-Progenics Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by Progenics, the license granted by the University to Progenics under Section 5.1.1 hereof shall likewise be automatically terminated to the same extent.
Appears in 2 contracts
Samples: 2010 Agreement Related to Progenics’s MNTX in License (Salix Pharmaceuticals LTD), License Agreement (Progenics Pharmaceuticals Inc)
Termination of Direct License to Progenics. In ProNev and Progenics hereby acknowledge that in the event that the sublicense granted by ProNev to Progenics under the UR Labs-Progenics Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by Progenics, the license granted by the University to Progenics under Section 5.1.1 hereof pursuant to the 2005 MNTX Agreement shall likewise be automatically terminated to the same extent.
Appears in 1 contract
Samples: 2008 Agreement Related to Progenics’ MNTX in License (Progenics Pharmaceuticals Inc)
Termination of Direct License to Progenics. In the event that the sublicense granted by ProNev to Progenics under the UR Labs-Progenics Agreement is terminated, in whole or in part, for an uncured material breach thereof caused by Progenics, the license granted by the University to Progenics under Section 5.1.1 hereof shall likewise be automatically terminated to the same extent.
Appears in 1 contract
Samples: Option and License Agreement (Progenics Pharmaceuticals Inc)